Let's keep in mind as per market cap comparison page on presentation that even at 5 cents we are still worth 30 mill which is still 3rd cheapest stock in the sector.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%